All News about Sanofi-Aventis S.A. ADR
![](https://cdn.benzinga.com/files/images/story/2024/05/31/Sanofi.jpeg?width=1200&height=800&fit=crop)
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
May 31, 2024
Via Benzinga
Exposures
Product Safety
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://g.foolcdn.com/editorial/images/776909/break-through-ceiling.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/29/Gary-Vaynerchuk-VaynorMedia-public-domai.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/28/Medical-Examination-And-Healthcare-Busin.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/778504/doctor-gives-person-a-shot.jpg)
![](https://investorplace.com/wp-content/uploads/2024/02/medical-biotech-stocks1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/22/Sick-Man-Working-In-The-Office--Has-A-Ba.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/05/22/Judge-Gavel--Scales-Of-Justice-And-Law-B.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://g.foolcdn.com/editorial/images/778118/gettyimages-1252566534.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/21/Artificial-Intelligence-ai-machine-Learn.jpeg?width=1200&height=800&fit=crop)
ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development
May 21, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://investorplace.com/wp-content/uploads/2023/05/meme-stocks-wallstreetbets1600-1024x576.png)
![](https://g.foolcdn.com/editorial/images/777323/doctor-vaccinating-a-patient.jpg)
![](https://g.foolcdn.com/editorial/images/777414/gettyimages-1294438458.jpg)
![](https://cdn.benzinga.com/files/front-view-doctor-holding-tubes.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/15/Mosquito.jpeg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20240515021224_is-doubleverifys-39-haircut-a-buying-opportunity.jpg)
Is DoubleVerify’s 39% Haircut a Buying Opportunity?
May 15, 2024
Via MarketBeat
![](https://investorplace.com/wp-content/uploads/2022/12/torn-dollar.jpg)
![](https://g.foolcdn.com/editorial/images/777293/gettyimages-pensive-investor-at-computer.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/meme-stocks-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/13/eiffel-tower-975004-1280.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/10/wall-street-bull.jpg)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
![](https://ml.globenewswire.com/media/7a8a3a11-c9ef-4891-bab7-c5b7db91c103/small/fulcrum-logo-primary-full-color-rgb-large-copy-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.